Reports for ABBVIE CORPORATION
Company Name
ABBVIE CORPORATION
Totals |
||
Shortage reports |
112 |
|
| Actual shortage: | 3 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 5 (4%) | |
| Resolved: | 104 (93%) | |
Discontinuation Reports |
9 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 8 (89%) | |
| Reversed: | 1 (11%) | |
Late reports |
3 (2%) |
|
Overdue reports |
1 (33%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CONSTELLA | 290MCG | CAPSULE | Resolved | 2022-06-09 | 2022-07-10 | 162248 |
| CONSTELLA | 72MCG | CAPSULE | Resolved | 2022-06-09 | 2022-07-10 | 162251 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-06-30 | 2022-08-27 | 163730 |
| PRED FORTE | 1% | DROPS DROPS | Resolved | 2022-10-04 | 2024-01-30 | 171004 |
| ZYMAR | 0.3% | SOLUTION | Resolved | 2022-10-13 | 2022-10-28 | 171699 |
| ACUVAIL | 0.45% | SOLUTION | Resolved | 2022-10-26 | 2023-04-29 | 172625 |
| FML | 0.1% | SUSPENSION DROPS | Resolved | 2022-11-29 | 2023-09-29 | 176192 |
| BYSTOLIC | 2.5MG | TABLET | Resolved | 2022-12-09 | 2023-01-19 | 177700 |
| VIIBRYD | 10MG | TABLET | Resolved | 2022-12-19 | 2023-02-09 | 178808 |
| VIIBRYD | 20MG | TABLET | Resolved | 2022-12-19 | 2023-01-27 | 178811 |
| RESTASIS | 0.05% | EMULSION | Resolved | 2023-01-10 | 2023-01-27 | 180339 |
| RESTASIS MULTIDOSE | 0.05% | EMULSION | Resolved | 2023-02-10 | 2023-03-02 | 184397 |
| BYSTOLIC | 10MG | TABLET | Resolved | 2023-03-22 | 2023-08-04 | 187625 |
| SKYRIZI | 90MG | SOLUTION | Actual shortage | 2023-03-30 | 2023-09-02 | 188265 |
| VIIBRYD | 10MG | TABLET | Resolved | 2023-05-15 | 2023-06-09 | 192501 |
| BYSTOLIC | 5MG | TABLET | Resolved | 2023-05-17 | 2024-02-06 | 192664 |
| ACULAR LS | 0.4% | SOLUTION | Resolved | 2023-06-06 | 2023-07-06 | 193833 |
| RESTASIS MULTIDOSE | 0.05% | EMULSION | Resolved | 2023-06-08 | 2023-07-20 | 194083 |
| FETZIMA | 120MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2023-07-21 | 2023-08-16 | 199542 |
| ALPHAGAN P | 0.15% | SOLUTION | Resolved | 2023-08-14 | 2023-12-14 | 201801 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MODERIBA | 600MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29835 |
| TECHNIVIE | 12.5MG 75MG 50MG | TABLET | Discontinued | 2017-11-20 | 2018-05-07 | 29839 |
| MODERIBA | 200MG | TABLET | Discontinued | 2017-11-21 | 2018-08-30 | 29907 |
| HOLKIRA PAK | 50MG 12.5MG 250MG 75MG | KIT TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31302 |
| MODERIBA | 400MG | TABLET | Discontinued | 2017-11-30 | 2018-08-30 | 31316 |
| NORVIR | 80MG | SOLUTION | Discontinued | 2019-02-20 | 2019-04-01 | 76354 |
| HUMIRA | 40MG | SOLUTION | Discontinued | 2020-06-29 | 2020-11-19 | 119141 |
| ALPHAGAN | 0.2% | LIQUID | Reversed | 2021-12-09 | 2023-12-14 | 150885 |
| LUPRON | 5MG | SOLUTION | Discontinued | 2022-01-31 | 2022-08-17 | 153896 |
Showing 1 to 9 of 9